XM does not provide services to residents of the United States of America.

Financials, healthcare drive Australian shares higher ahead of GDP data



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Financials, healthcare drive Australian shares higher ahead of GDP data</title></head><body>

June 5 (Reuters) -Australian shares inched higher on Wednesday, as gains in banks and healthcare stocks outweighed losses in commodity-related sectors, while investors awaited March-quarter economic growth data due later in the day for further direction.

The S&P/ASX 200 index .AXJO rose 0.2% to 7,750.7 by 0030 GMT. The benchmark fell 0.3% on Tuesday.

The gross domestic product (GDP) data due at 0130 GMT is likely to show a growth of 0.2%, according to a Reuters poll.

Data released on Tuesday showed Australia's current account unexpectedly swung into deficit in the March quarter as imports jumped and prices for commodity exports fell, possibly taking a chunk out of the GDP.

Gains at the bourse were led by healthcare firms .AXHJ, with the sub-index rising 1.1% to its highest in three weeks. The real estate sub-index .AXRE climbed 1.6%.

Rate-sensitive financials .AXFJ rose 0.5%, with the "Big Four" banks up between 0.3% and 0.7%.

Bucking the trend, miners .AXMM on the resources-heavy bourse dipped 1.4%, nearing a one-month low. Sector behemoths BHP BHP.AX, Rio Tinto RIO.AX, and Fortescue FMG.AX were trading lower by 1.1%, 1.2%, and 0.7% respectively

Iron ore futures were near their lowest in seven weeks, as signs of weakening demand in top consumer China and lingering high portside inventories weighed on the market. IRONORE/

Gold stocks .AXGD were down 1.8% after bullion prices dropped overnight on caution over the U.S. Federal Reserve's interest rate strategy.GOL/

Energy stocks .AXEJ fell 1.1% as global oil prices declined on investor worries over shaky demand. O/R

Across the Tasman Sea, New Zealand's benchmark S&P/NZX 50 index .NZ50 was down 0.1% at 11,863.6.



Reporting by Prerna Bedi in Bengaluru; Editing by Subhranshu Sahu

For more information on DIARIES & DATA: U.S. earnings diary RESF/US Wall Street Week Ahead .N/O Global Economy Week Ahead DATA/ ................................................................ For latest top breaking news across all markets NEWS1
</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.